News | Stroke | November 03, 2015

New Patient Engagement Materials Released on Prevention, Treatment of AF-related Stroke

Documents, infographics and video discuss how to lower stroke risks and guide medical care, atrial fibrillation, AF-related stroke, patient engagement materials

Infographic courtesy of

November 3, 2015 — In recognition of World Stroke Day, the patient-focused organization launched a diverse set of materials for engaging and empowering people living with atrial fibrillation (AF). The materials are intended to increase the ability of patients to be engaged in their own treatment and stroke prevention decisions.

The materials are the result of a year-long initiative by a committee of the Sign Against Stroke (SAS) Task Force comprised of five patient and professional advocacy organizations to create materials to be used globally. The committee is chaired by, based in the United States. Committee members include Arrythmia Alliance Argentina (Argentina), Asian Pacific Society of Cardiology (Singapore), Associacao Bate, Bate Coracao (Portugal), and Fundacja Udaru Mozgu (Poland). 

The idea originated at a global summit where member groups noted that the socioeconomic and personal burdens of AF-related stroke are high and devastating to individuals, yet many patients do not understand what atrial fibrillation is, what their stroke risk actually is and how they can prevent AF-related stroke. The task force also expressed a shared belief that many patients do not understand that it is their right to ask questions of their doctor and to participate in their treatment decisions based on the best available evidence.

The task force agreed to address these concerns through the development of a set of educational materials that could be readily translated into other languages and adapted to different cultures. They started gathering input from regional patient group summits in late 2014. 

The materials consist of five downloadable documents, two infographics and an animated video.

The five downloadable documents each focus on a specific topic:

  • About AF:  Interpreting your diagnosis and treatment options; 
  • Lower Stroke Risks:  Evidence and information to help people with AF make decisions to minimize stroke risk;
  • Questions to ask about AF:  Questions for patients to ask their healthcare providers and encourage a two-way dialogue;  
  • Getting the Best AF Care:  Guidance on how patients can communicate with physicians and advocate for their own care; and
  • Help from Family and Friends:  Ways family carers can provide support for loved ones. 

The video is three minutes long and features several messages about the dangers of AF and the importance of knowing your risks and developing a treatment plan with your doctor. The video can be made into eight mini videos of 20 to 30 seconds each for wider use and dissemination across a variety of channels.

Each of the two infographics offers facts and figures designed to enhance awareness of AF and the resulting stroke risk.

"Many people with AF are not aware of their increased risk of stroke," said Mellanie True Hills, CEO of "These materials are designed to educate patients about managing their risk and to mobilize them to become active partners in their care."

The materials are being launched globally in multiple languages, with a focus on Europe, Asia, and Latin America. They will be shared at an upcoming patient group symposium in Warsaw, Poland in November, where as many as 50 organizations from throughout Europe will be provided the materials with tools to facilitate their translation and localization.

For more information:

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Image courtesy of Michigan Medicine

News | Hypertension| September 06, 2017
A new National Institutes of Health-funded hypertension trial will examine the possibility of using an emergency...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Overlay Init